Sign In
Buy LMND
Lemonade Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | -$0.720 |
| EPS actual | -$0.510 |
| EPS Surprise | 29.17% |
| Revenue estimate | 216.786M |
| Revenue actual | 194.5M |
| Revenue Surprise | -10.28% |
| Release date | Aug 05, 2025 |
| EPS estimate | -$0.81 |
| EPS actual | -$0.600 |
| EPS Surprise | 25.93% |
| Revenue estimate | 183.975M |
| Revenue actual | 164.1M |
| Revenue Surprise | -10.80% |
| Release date | May 06, 2025 |
| EPS estimate | -$0.94 |
| EPS actual | -$0.86 |
| EPS Surprise | 8.51% |
| Revenue estimate | 144.98M |
| Revenue actual | 151.2M |
| Revenue Surprise | 4.29% |
| Release date | Feb 25, 2025 |
| EPS estimate | -$0.610 |
| EPS actual | -$0.420 |
| EPS Surprise | 31.15% |
| Revenue estimate | 144.783M |
| Revenue actual | 148.8M |
| Revenue Surprise | 2.77% |
Last 4 Quarters for Lemonade
Below you can see how LMND performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 25, 2025 |
| Price on release | $31.99 |
| EPS estimate | -$0.610 |
| EPS actual | -$0.420 |
| EPS surprise | 31.15% |
| Date | Price |
|---|---|
| Feb 19, 2025 | $36.54 |
| Feb 20, 2025 | $35.21 |
| Feb 21, 2025 | $33.42 |
| Feb 24, 2025 | $34.70 |
| Feb 25, 2025 | $31.99 |
| Feb 26, 2025 | $31.48 |
| Feb 27, 2025 | $35.46 |
| Feb 28, 2025 | $36.35 |
| Mar 03, 2025 | $35.75 |
| 4 days before | -12.45% |
| 4 days after | 11.75% |
| On release day | -1.59% |
| Change in period | -2.16% |
| Release date | May 06, 2025 |
| Price on release | $30.31 |
| EPS estimate | -$0.94 |
| EPS actual | -$0.86 |
| EPS surprise | 8.51% |
| Date | Price |
|---|---|
| Apr 30, 2025 | $29.22 |
| May 01, 2025 | $28.51 |
| May 02, 2025 | $30.00 |
| May 05, 2025 | $30.00 |
| May 06, 2025 | $30.31 |
| May 07, 2025 | $30.55 |
| May 08, 2025 | $31.22 |
| May 09, 2025 | $31.07 |
| May 12, 2025 | $31.97 |
| 4 days before | 3.73% |
| 4 days after | 5.48% |
| On release day | 0.792% |
| Change in period | 9.41% |
| Release date | Aug 05, 2025 |
| Price on release | $47.93 |
| EPS estimate | -$0.81 |
| EPS actual | -$0.600 |
| EPS surprise | 25.93% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $36.28 |
| Jul 31, 2025 | $37.68 |
| Aug 01, 2025 | $36.40 |
| Aug 04, 2025 | $37.00 |
| Aug 05, 2025 | $47.93 |
| Aug 06, 2025 | $51.07 |
| Aug 07, 2025 | $47.26 |
| Aug 08, 2025 | $48.98 |
| Aug 11, 2025 | $52.37 |
| 4 days before | 32.11% |
| 4 days after | 9.26% |
| On release day | 6.55% |
| Change in period | 44.35% |
| Release date | Nov 05, 2025 |
| Price on release | $78.73 |
| EPS estimate | -$0.720 |
| EPS actual | -$0.510 |
| EPS surprise | 29.17% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $59.01 |
| Oct 31, 2025 | $60.08 |
| Nov 03, 2025 | $61.54 |
| Nov 04, 2025 | $58.66 |
| Nov 05, 2025 | $78.73 |
| Nov 06, 2025 | $75.13 |
| Nov 07, 2025 | $75.02 |
| Nov 10, 2025 | $78.89 |
| Nov 11, 2025 | $79.14 |
| 4 days before | 33.42% |
| 4 days after | 0.521% |
| On release day | -4.57% |
| Change in period | 34.11% |
Lemonade Earnings Call Transcript Summary of Q3 2025
Lemonade reported a strong Q3 2025 with accelerated top-line growth and improving profitability metrics. Key operating results: in-force premium grew 30% YoY to $1.16B, revenue grew 42% YoY to $195M, gross profit and adjusted gross profit more than doubled (gross margin ~41%, adjusted gross margin ~42%), Q3 gross loss ratio was a record-low 62% (trailing 12-month 67%), and adjusted EBITDA loss improved to -$26M (from -$49M prior year). Net loss narrowed to $38M and adjusted free cash flow was positive for the second straight quarter ($18M). The company added a record ~176k net new customers and continued strong cross-sell dynamics (over half of new car policies were to existing Lemonade customers, effectively CAC-less). AI/automation is a core driver: LAE has been cut in half over 3 years to ~7% and claims adjuster productivity has tripled via the internal AI platform. Balance sheet and liquidity remain strong with ~$1.1B in cash and investments; management reiterated guidance for full-year 2025 upgrades across several metrics and maintained the target of adjusted EBITDA profitability in Q4 2026. Management emphasized they are optimizing for absolute gross profit dollars (not a fixed loss-ratio target), will selectively trade margin for growth where it increases gross profit, and expect ongoing reinsurance ceding rate declines (effective ceding ~40% in Q4 due to quota share changes).
